Wang YF, Tadimalla S, Hayden AJ, Holloway L, Haworth A (2021) Artificial intelligence and imaging biomarkers for prostate radiation therapy during and after treatment. J Med Imaging Radiat Oncol 65(5):612–626

Article  Google Scholar 

Sun Y, Reynolds HM, Wraith D, Williams S, Finnegan ME, Mitchell C, Murphy D, Haworth A (2018) Voxel-wise prostate cell density prediction using multiparametric magnetic resonance imaging and machine learning. Acta Oncol 57(11):1540–1546

Article  PubMed  Google Scholar 

Sun Y, Reynolds HM, Wraith D, Williams S, Finnegan ME, Mitchell C, Murphy D, Haworth A (2019) Automatic stratification of prostate tumour aggressiveness using multiparametric MRI: a horizontal comparison of texture features. Acta Oncol 58(8):1118–1126

Article  PubMed  Google Scholar 

Sun Y, Williams S, Byrne D, Keam S, Reynolds HM, Mitchell C, Wraith D, Murphy D, Haworth A (2019) Association analysis between quantitative MRI features and hypoxia-related genetic profiles in prostate cancer: a pilot study. Br J Radiol 92(1104):20190373

Article  PubMed  PubMed Central  Google Scholar 

Hompland T, Hole KH, Ragnum HB, Aarnes EK, Vlatkovic L, Lie AK, Patzke S, Brennhovd B, Seierstad T, Lyng H (2018) Combined MR imaging of oxygen consumption and supply reveals tumor hypoxia and aggressiveness in prostate cancer patients. Cancer Res 78(16):4774–4785

Article  CAS  PubMed  Google Scholar 

Leech M, Osman S, Jain S, Marignol L (2021) Mini review: personalization of the radiation therapy management of prostate cancer using MRI-based radiomics. Cancer Lett 498:210–216

Article  CAS  PubMed  Google Scholar 

Scalco E, Rancati T, Pirovano I, Mastropietro A, Palorini F, Cicchetti A, Messina A, Avuzzi B, Valdagni R, Rizzo G (2018) Texture analysis of T1-w and T2-w MR images allows a quantitative evaluation of radiation-induced changes of internal obturator muscles after radiotherapy for prostate cancer. Med Phys 45(4):1518–1528

Article  PubMed  Google Scholar 

Lee SL, Lee J, Craig T, Berlin A, Chung P, Menard C, Foltz WD (2019) Changes in apparent diffusion coefficient radiomics features during dose-painted radiotherapy and high dose rate brachytherapy for prostate cancer. Phys Imaging Radiat Oncol 9:1–6

Article  PubMed  Google Scholar 

Gurney-Champion OJ, Mahmood F, van Schie M, Julian R, George B, Philippens MEP, van der Heide UA, Thorwarth D, Redalen KR (2020) Quantitative imaging for radiotherapy purposes. Radiother Oncol 146:66–75

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Connor JP, Rose CJ, Waterton JC, Carano RA, Parker GJ, Jackson A (2015) Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res 21(2):249–257

Article  CAS  PubMed  Google Scholar 

De Visschere PJL, Standaert C, Futterer JJ, Villeirs GM, Panebianco V, Walz J, Maurer T, Hadaschik BA, Lecouvet FE, Giannarini G, Fanti S (2019) A systematic review on the role of imaging in early recurrent prostate cancer. Eur Urol Oncol 2(1):47–76

Article  PubMed  Google Scholar 

Daniel M, Kuess P, Andrzejewski P, Nyholm T, Helbich T, Polanec S, Dragschitz F, Goldner G, Georg D, Baltzer P (2019) Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer. Strahlenther Onkol 195(5):402–411

Article  CAS  PubMed  Google Scholar 

Tharmalingam H, Tsang YM, Alonzi R, Beasley W, Taylor NJ, McWilliam A, Padhani A, Choudhury A, Hoskin PJ (2022) Changes in magnetic resonance imaging radiomic features in response to androgen deprivation therapy in patients with intermediate- and high-risk prostate cancer. Clin Oncol (R Coll Radiol) 34(6):e246–e253

Article  CAS  PubMed  Google Scholar 

McPartlin A, Kershaw L, McWilliam A, Taylor MB, Hodgson C, van Herk M, Choudhury A (2018) Changes in prostate apparent diffusion coefficient values during radiotherapy after neoadjuvant hormones. Ther Adv Urol 10(12):359–364

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pasquier D, Hadj Henni A, Escande A, Tresch E, Reynaert N, Colot O, Lartigau E, Betrouni N (2018) Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer. Sci Rep 8(1):10407

Article  PubMed  PubMed Central  Google Scholar 

van Schie MA, van Houdt PJ, Ghobadi G, Pos FJ, Walraven I, de Boer HCJ, van den Berg CAT, Smeenk RJ, Kerkmeijer LGW, van der Heide UA (2019) Quantitative MRI changes during weekly ultra-hypofractionated prostate cancer radiotherapy with integrated boost. Front Oncol 9:1264

Article  PubMed  PubMed Central  Google Scholar 

Wu X, Reinikainen P, Kapanen M, Vierikko T, Ryymin P, Kellokumpu-Lehtinen PL (2019) Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI). Diagn Interv Imaging 100(11):699–708

Article  CAS  PubMed  Google Scholar 

Li SP, Padhani AR (2012) Tumor response assessments with diffusion and perfusion MRI. J Magn Reson Imaging 35(4):745–763

Article  PubMed  Google Scholar 

Park SY, Kim CK, Park BK, Park W, Park HC, Han DH, Kim B (2012) Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 83(2):749–755

Article  PubMed  Google Scholar 

Foltz WD, Wu A, Chung P, Catton C, Bayley A, Milosevic M, Bristow R, Warde P, Simeonov A, Jaffray DA, Haider MA, Menard C (2013) Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer. J Magn Reson Imaging 37(4):909–916

Article  PubMed  Google Scholar 

Decker G, Murtz P, Gieseke J, Traber F, Block W, Sprinkart AM, Leitzen C, Buchstab T, Lutter C, Schuller H, Schild HH, Willinek WA (2014) Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T. Radiother Oncol 113(1):115–120

Article  PubMed  Google Scholar 

Liu L, Wu N, Ouyang H, Dai JR, Wang WH (2014) Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer. Br J Radiol 87(1043):20140359

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iannelli G, Caivano R, Rago L, Simeon V, Lotumolo A, Rabasco P, Villonio A, Gioioso M, Mastrangelo P, Barchetti F, Panebianco V, Macarini L, Guglielmi G, Cammarota A (2016) Diffusion-weighted magnetic resonance imaging in patients with prostate cancer treated with radiotherapy. Tumori 102(1):71–76

Article  CAS  PubMed  Google Scholar 

Vaz S, Falkmer T, Passmore AE, Parsons R, Andreou P (2013) The case for using the repeatability coefficient when calculating test-retest reliability. PLoS ONE 8(9):e73990

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almansour H, Schick F, Nachbar M, Afat S, Fritz V, Thorwarth D, Zips D, Bertram F, Muller AC, Nikolaou K, Othman AE, Wegener D (2023) Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study. Radiol Oncol 57(2):184–190

Article  PubMed  PubMed Central  Google Scholar 

Fedorov A, Vangel MG, Tempany CM, Fennessy FM (2017) Multiparametric magnetic resonance imaging of the prostate: repeatability of volume and apparent diffusion coefficient quantification. Invest Radiol 52(9):538–546

Article  PubMed  PubMed Central  Google Scholar 

Raunig DL, McShane LM, Pennello G, Gatsonis C, Carson PL, Voyvodic JT, Wahl RL, Kurland BF, Schwarz AJ, Gonen M, Zahlmann G, Kondratovich MV, O’Donnell K, Petrick N, Cole PE, Garra B, Sullivan DC, Group QTPW (2015) Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. Stat Methods Med Res 24(1):27–67

Article  PubMed  Google Scholar 

Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, Huang W, Noworolski SM, Young RJ, Shiroishi MS, Kim H, Coolens C, Laue H, Chung C, Rosen M, Boss M, Jackson EF (2019) Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging 49(7):e101–e121

Article  PubMed  Google Scholar 

Gibbs P, Tozer DJ, Liney GP, Turnbull LW (2001) Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 46(6):1054–1058

Article  CAS  PubMed  Google Scholar 

Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, Bostrom PJ, Pahikka